Merit Medical Systems Inc. (MMSI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Merit Medical Systems Inc. (MMSI) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How MMSI Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | 48.7% | 12.2% | $128.5M | $215.7M | 7.8% |
| FY 2024 | $1.36B | 47.4% | 11.5% | $120.4M | $185.7M | 7.1% |
| FY 2023 | $1.26B | 44% | 9.9% | $94.4M | $88.6M | 5.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring MMSI)
- ✓Live walkthrough of MMSI's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
MMSI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +11.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MMSI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MMSI. Explore sector supply chains on /butterfly.
MMSI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Merit Medical Systems Inc. (MMSI)?
In FY 2025 (10-K), MMSI converted $1.5B of revenue into a 48.7% gross margin, 12.2% operating margin, and $215.7M in free cash flow (14.2% FCF margin).